Visiting Scholar at National Cancer Centre Singapore. | Medical Oncologist at Beijing Chest Hospital, China

Singapore
Joined November 2023
The biennial ACORD Workshop wrapped up after an intense week in spring Sydney. Deeply inspired by everyone’s professionalism. End of one journey, start of another😊 I went in, I survived. #ACORD
1
5
63
Delighted to share our two newly published Editorial Commentaries on EGFR-mutated NSCLC. Many thanks to my friend Aaron Tan for the invitation — it’s always a pleasure working with all the friends. Looking forward to more collaborations ahead!@aaronctan @rooogerthat #LungCancer
6
189
Grateful for this wonderful collaboration. Many thanks to Stephanie and all co-authors for putting together this great work!@stephanieplsaw @DrYujiUehara @drkevin_chua_lm
How far have we come treating EGFRm NSCLC and what new dilemmas do we face? We discuss biomarkers, rationalising options and challenging clinical scenarios. Always a pleasure to write with friends ☺️ @DrYujiUehara @hiroto_pulm @JiefeiHan @drkevin_chua_lm mdpi-res.com/d_attachment/ca…
2
6
354
Truly honored to have attended this insightful meeting! Thanks to Herbert and Molly for organizing, bringing together friends across the Asia-Pacific to share cutting-edge research and build collaborations. As Stephanie said, "To do what you love with people you love"
We held our 1st Conversations in Thoracic Oncology Asia Pacific #CiTOAP26 at @CUHKMedicine @CUHK_MC welcoming over 10 thoracic oncologists from #ChineseMainland, #Taiwan, #Singapore, #Japan, #Korea and #HongKong to present their research and discuss insights with an aim to build mutual collaborations. Honoured to have @TonyMok9 kick the meeting off with an extremely insightful talk on how to best collaborate with #industry! It was a long but extremely fruitful day for over 50 participants and I want to thank everyone involved for your very generous sharing and active discussions! Our thanks to @TakedaPharma and the #HKSocietyofMedicalOncology for sponsoring and supporting this inaugural event. Thanks @mollylisc for co-hosting this event with me! 😀🙏 @stephanieplsaw #WuFang @DrYujiUehara #DerekHuang @abcduke #FeiFeiTeng #LiuSiYang(Maggie) #JonathanShiFengNyaw #MacyTong @JiefeiHan @apoddc @APCLC_2023 @LungPolicy @IASLC #ATORG
4
129
Excited to be heading to Hong Kong next week for Conversations in Thoracic Oncology Asia Pacific 2026! Honored to join this amazing lineup of speakers, and can’t wait to catch up with everyone🍻@herbloong @mollylisc @DrYujiUehara @stephanieplsaw
Replying to @mollylisc
@mollylisc and I are looking forward to hosting Conversations In Thoracic Oncology 2026 (#CITO26) 🫁 at @CUHK_MC in 2+ weeks' time in #HongKong! Welcoming speakers who are #RisingStars 🌟 in #ThoracicOncology from #HongKong 🇭🇰, #Japan 🇯🇵, #Taiwan 🇹🇼, #ChineseMainland 🇨🇳, #Singapore 🇸🇬 and #SouthKorea 🇰🇷. @stephanieplsaw @DrYujiUehara @TonyMok9 amongst many others! @apoddc @APCLC_2023 #drugdevelopment @IASLC
4
9
823
🎉 Great to welcome Aaron, Amit and Yu Yang to Beijing for the 4th INSPIRE! Our team is bigger than ever, and it's been amazing to have you all at Beijing Chest Hospital for deep collaborative discussions. Looking forward to meet again soon!
1
4
151
A new journey begins. I officially joined Beijing Chest Hospital this month, returning to the field of lung cancer—work I have long been dedicated to. Looking forward to cooperation with all my friends. Let's keep moving forward together!
1
7
437
Though the weather is freezing cold, the discussions were warm and engaging—and the drinks and hotpot were fantastic! Nothing beats the joy of meeting friends from far😁
6
107
A fantastic conference with exceptional talk, hospitality, food, and invaluable global networking opportunities in Hong Kong🇭🇰. #ESMOTATAsia25 The growing importance of Asian collaboration is evident. I'm looking forward to joining next year's event! @myESMO
1
2
22
1,263
ESMO TAT ASIA was fantastic. Learned a ton at the Early Drug Dev course. Typhoon has me stuck. Flight delayed to 15:00, booked train to escape but also cancelled. Whatever, it’s always fun catching up with you guys! Looks like I got the earliest flight. Will update if I make it!
2
1
10
139
Boarding now🙏
3
51
A year in Singapore flew by Heartfelt thanks to Daniel, NCCS team, and every friend I met.
So much learned, yet still more to explore.
Beijing awaits. Let’s continue journey together. It is the beginning, not the end.
1
1
8
384
Two fulfilling days in Kuala Lumpur—thanks to @drdaviddwlee for the invitation and hospitality! Learned so much from ATORG and hope to host it in Beijing someday. Loved spending time with cheerful, creative friends. Happy Chinese New Year to all!🎉🎊#ATORG
11
540
🌟First Christmas & New Year in Singapore! Grateful for the festive vibes at NCCS lung meeting and all the wonderful people I've met here. The holiday spirit at NCCS makes this academic journey even more special! 🎄✨ #NCCS #Singapore #MedicalJourney
7
619
Delighted to attend the National Cancer Center Forum & International Symposium on Progress in Lung Cancer Research (INSPIRE). Had great discussions on ICIs for driver gene+ NSCLC with my friends. See you next time! @drdaviddwlee @mollylisc @jii_bum_lee @aaronctan @yysoon01
2
7
565
Delighted to attend the National Cancer Center Forum & International Symposium on Progress in Lung Cancer Research (INSPIRE). Had great discussions on ICIs for driver gene+ NSCLC with my friends. See you next time! @mollylisc@drdaviddwlee@jii_bum_lee@@aaronctan@yysoon01
2
8
310
Pooled analysis of LUOSICNS and OUTRUN trials highlighted by Prof Wang Lin from the Cancer Hospital of The Chinese Academy of Medical Sciences at the National Cancer Centre Forum on Translational Oncology & International Symposium on Progress in Lung Cancer Research (INSPIRE).
1
2
1
7
724
After 7 years, back at ESMO Asia! So happy to reconnect with old friends, meet new ones, and learn so much. Amazing conference! #ESMOAsia
9
270
Great learning opportunity. Thanks to the LCCS workshop! #LCCS #NCCS
3
142
🔥#ACLC24 @IASLC Asia🌏 🗣️Oral Abstract Session 1 ✅Chairs: Drs. Duan jianchun, Xiuhao Zhang 🎙️@ThomasW35874311 🎯Zongertinib (BI 1810631) in Patients with HER2-Driven Tumors: Phase Ia and Phase Ib Analysis of Beamion LUNG-1 #LCSM @OncoAlert aclc2024-iaslc.org
🔜#ACLC24 @IASLC Asia🌏 🔥Oral Abstract Session 1 ✅Chairs: Drs. Duan jianchun, Xiuhao Zhang 🎙️Drs. @HHorinouchi Drs. Xiaolong Huang Yi Fung Chau @ThomasW35874311 #LCSM @OncoAlert aclc2024-iaslc.org/
5
10
2,169